Biodegradable nanoparticles designed for drug delivery: The number of nanoparticles impacts on cytotoxicity

Toxicology in Vitro

Volumn 29, Issue 6, 2015, Pages 1268-1274

  Mendes, Lívia Palmerston ^a   Delgado, Jorge Miguel Ferreira ^b   Costa, Angela Daniela A ^b   Vieira, Marcelo Sousa ^a   Benfica, Poliana Lopes ^a   Lima, Eliana Martins ^a   Valadares, Marize Campos ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b INSTITUTO POLITÉCNICO DE BRAGANÇA   (Portugal)

Author keywords

In vitro cytotoxicity; Nanoparticles

Indexed keywords

BIODEGRADABLE NANOPARTICLE; LIPOSOME; NANOCAPSULE; NANOPARTICLE; NANOSPHERE; NANOSTRUCTURED LIPID CARRIER; POLYMERIC NANOCAPSULE; UNCLASSIFIED DRUG; LIPID; POLYCAPROLACTONE; POLYESTER;

3T3 CELL LINE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL SURFACE; CELL VIABILITY; CHEMICAL PHENOMENA; COLLOIDAL DISPERSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; FIBROBLAST; HEMOLYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; INTERNALIZATION; LYMPHOCYTE; MOLECULAR DYNAMICS; MOUSE; MTT ASSAY; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; STRUCTURE ACTIVITY RELATION; SURFACE CHARGE; ZETA POTENTIAL; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS;

ANIMALS; BALB 3T3 CELLS; CELL SURVIVAL; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; HEMOLYSIS; HUMANS; LIPIDS; LYMPHOCYTES; MICE; NANOPARTICLES; POLYESTERS;

EID: 84930818774     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.12.021     Document Type: Article

References (34)

1. Afshari M., Derakhshandeh K., Hosseinzadeh L. Characterisation, cytotoxicity and apoptosis studies of methotrexate-loaded PLGA and PLGA-PEG nanoparticles. J. Microencapsul. 2014, 31:239-245.
2. Arora S., Rajwade J.M., Paknikar K.M. Nanotoxicology and in vitro studies: the need of the hour. Toxicol. Appl. Pharmacol. 2012, 258:151-165.
3. Borenfreund E., Puerner J. A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90). J. Tissue Culture Methods 1985, 9:7-9.
4. Chang H.-I., Yeh M.-K. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int. J. Nanomed. 2012, 7:49-60.
5. Cordewener F.W., van Geffen M.F., Joziasse C.A.P., Schmitz J.P., Bos R.R.M., Rozema F.R., Pennings A.J. Cytotoxicity of poly(96L/4D-lactide): the influence of degradation and sterilization. Biomaterials 2000, 21:2433-2442.
6. Doktorovova S., Souto E.B., Silva A.M. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data. Eur. J. Pharm. Biopharm. 2014, 87:1-18.
7. Elsaesser A., Howard C.V. Toxicology of nanoparticles. Adv. Drug Deliv. Rev. 2012, 64:129-137.
8. Frohlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 2012, 7:5577-5591.
9. Gaeti M.P.N., Benfica P.L., Mendes L.P., Vieira M.S., Anjos J.L.V., Alonso A., Rezende K.R., Valadares M.C., Lima E.M. Liposomal entrapment of 4-nerolidylcatechol: impact on phospholipid dynamics, drug stability and bioactivity. J. Nanosci. Nanotechnol. 2015, 15:838-847.
10. Hashem F.M., Nasr M., Khairy A. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate. Pharm. Dev. Technol. 2014, 19:824-832.
11. Hillegass J.M., Shukla A., Lathrop S.A., MacPherson M.B., Fukagawa N.K., Mossman B.T. Assessing nanotoxicity in cells in vitro. Wiley Interdiscip Rev. Nanomed. Nanobiotechnol. 2010, 2:219-231.
12. ICCVAM, 2006. Test Method Evaluation Report (TMER): In vitro Cytotoxicity Test Methods for Estimating Starting Doses for Acute Oral Systemic Toxicity Tests. NIH publication No. 07-4519. Research Triangle Park, NC: National Institute for Environmental Health Sciences.
13. Jones C.F., Grainger D.W. In vitro assessments of nanomaterial toxicity. Adv. Drug Deliv. Rev. 2009, 61:438-456.
14. Kasongo K.W., Mueller R.H., Walker R.B. The use of hot and cold high pressure homogenization to enhance the loading capacity and encapsulation efficiency of nanostructured lipid carriers for the hydrophilic antiretroviral drug, didanosine for potential administration to paediatric patients. Pharm. Dev. Technol. 2012, 17:353-362.
15. Kim M.J., Shin S. Toxic effects of silver nanoparticles and nanowires on erythrocyte rheology. Food Chem. Toxicol. 2014, 67:80-86.
16. Kong B., Seog J.H., Graham L.M., Lee S.B. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine 2011, 6:929-941.
17. Love S.A., Maurer-Jones M.A., Thompson J.W., Lin Y.S., Haynes C.L. Assessing nanoparticle toxicity. Annu. Rev. Anal. Chem. 2012, 5(5):181-205.
18. Mendes L.P., Nogueira Gaeti M.P., Marcelino de Avila P.H., Vieira M.d.S., Rodrigues B.d.S., de Avila Marcelino R.I., Rosa dos Santos L.C., Valadares M.C., Lima E.M. Multicompartimental nanoparticles for co-encapsulation and multimodal drug delivery to tumor cells and neovasculature. Pharm. Res. 2014, 31:1106-1119.
19. Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 2009, 234:222-235.
20. Mora-Huertas C.E., Garrigues O., Fessi H., Elaissari A. Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: comparative study. Eur. J. Pharm. Biopharm. 2012, 80:235-239.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
22. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
23. Nogueira D.R., del Carmen Moran M., Mitjans M., Perez L., Ramos D., de Lapuente J., Pilar Vinardell M. Lysine-based surfactants in nanovesicle formulations: the role of cationic charge position and hydrophobicity in in vitro cytotoxicity and intracellular delivery. Nanotoxicology 2014, 8:404-421.
24. Oliveira R.R., Ferreira S.F., Cintra E.R., Branquinho L.C., Bakuzis A.F., Lima E.M. Magnetic nanoparticles and rapamycin encapsulated into polymeric nanocarriers. J. Biomed. Nanotechnol. 2012, 8(2):193-201.
25. Olson F., Hunt C.A., Szoka F.C., Vail W.J., Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 1979, 557:9-23.
26. O'Reilly L.P., Luke C.J., Perlmutter D.H., Silverman G.A., Pak S.C. C. elegans in high-throughput drug discovery. Adv. Drug Deliv. Rev. 2014, 69-70:247-253.
27. Ridolfi D.M., Marcato P.D., Machado D., Silva R.A., Justo G.Z., Durán N. In vitro cytotoxicity assays of solid lipid nanoparticles in epithelial and dermal cells. J. Phys: Conf. Ser. 2011, 304.
28. Santos Júnior H., Oliveira D., Carvalho D., Pinto J., Campos V., Mourão A., Pessoa C., Moraes M., Costa-Lotufo L. Evaluation of native and exotic Brazilian plants for anticancer activity. J. Nat. Med. 2010, 64:231-238.
29. Shang L., Nienhaus K., Nienhaus G.U. Engineered nanoparticles interacting with cells: size matters. J. Nanobiotechnol. 2014, 12:5.
30. Singh R.P., Ramarao P. Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol. Lett. 2012, 213:249-259.
31. Souza L.G., Silva E.J., Martins A.L.L., Mota M.F., Braga R.C., Lima E.M., Valadares M.C., Taveira S.F., Marreto R.N. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur. J. Pharm. Biopharm. 2011, 79:189-196.
32. Stecanella L.A., Taveira S.F., Marreto R.N., Valadares M.C., Vieira M.d.S., Kato M.J., Lima E.M. Development and characterization of PLGA nanocapsules of grandisin isolated from Virola surinamensis: in vitro release and cytotoxicity studies. Revista Brasileira de Farmacognosia 2013, 23:153-159.
33. Verma A., Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
34. Vorup-Jensen T., Peer D. Nanotoxicity and the importance of being earnest. Adv. Drug Deliv. Rev. 2012, 64:1661-1662.